Inside Washington: Medication Safety in the Limelight

Wechsler,Jill;

Publication

Article

May 15, 2003

BioPharm International

BioPharm International-05-01-2003

Volume16

Issue 5

Inside Washington: Medication Safety in the Limelight

Author(s):

Jill Wechsler

by Jill Wechsler, BioPharm International FDA proposes bar codes on drug packages and new error reporting standards as part of its campaign to reduce medication errors.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Demonstrating the Consistency of Small Data Sets: Application of the Weisberg t-test for Outliers

Sumeria to Satellites: Evolution of the Bioreactor

Patent Law: Extracting Maximum Value from Your Patent Portfolio

A Statistical Method to Account for Plate-to-Plate Variability in Multiple-Plate Bioassays

Inside Washington: Medication Safety in the Limelight

Part 11 Is Not Going Away: The New Electronic Records Draft Guidance

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!